SCHEMBL25880422

SCHEMBL25880422

c1ccc(-c2cccc(-c3ccc4c(c3)c3c(-c5cccc(-c6ccccc6)c5)ccc5c3n4c3ccc(-c4cccc(-c6ccccc6)c4)c4c6cc(-c7cccc(-c8ccccc8)c7)ccc6n5c43)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.35
NR3C1 P04150 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
APAF1 O14727 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
XBP1 P17861 1/20 0.34
PTBP1 P26599 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
GALK1 P51570 1/20 0.34
BLM P54132 1/20 0.34
SMAD3 P84022 1/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25880425 0.94 NR3C1 (0.35) ALKNR3C1MEN1KMT2AAPAF1
SCHEMBL25880382 0.91 HSD17B10 (0.36) ALKNR3C1MEN1KMT2AAPAF1
SCHEMBL25880419 0.84 MEN1 (0.34) MEN1KMT2AAPAF1NPC1LMNA
SCHEMBL25459786 0.84 TSPO (0.41) MEN1KMT2AAPAF1NPC1LMNA
SCHEMBL25880383 0.84 HSD17B10 (0.35) MEN1KMT2AAPAF1NPC1LMNA
SCHEMBL25880411 0.84 HSD17B1 (0.38) NR3C1MEN1KMT2ANPC1MAPT
SCHEMBL25459795 0.83 TSPO (0.38) MEN1KMT2AMAPTHTTTSPO
SCHEMBL25880402 0.83 HSD17B10 (0.37) NR3C1MAPTL3MBTL1
SCHEMBL25459746 0.81 TSPO (0.38) ALKMEN1KMT2AAPAF1NPC1
SCHEMBL25459787 0.81 TSPO (0.38) ALKMEN1KMT2AAPAF1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 ALK 2384/4885NR3C1 614/4885MEN1 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.